EMAIL
| PRINT
| REPORT TYPO
| SEND YOUR FEEDBACK
|
Health hazard alert for drug Desire expanded to include additional lot
- June 9, 2008 9:30 AM
- By Peter Hadzipetros
Health Canada is expanding an earlier health-hazard alert for the product Desire, a male sexual performance drug that has not been authorized for sale in Canada.
The advisory now includes Lot 84881 in addition to Lot 0070263. The federal agency says the drug contains phentolamine, a prescription medication that should only be taken under the supervision of a health care professional.
Use of phentolamine in patients may cause side-effects including dizziness, loss of consciousness, prolonged erection, headache and abdominal pain.
The drug is manufactured by Desire LLC and distributed by New York-based StarChem Labs.
Consumers with questions can call Health Canada at 1-866-225-0709.
About the Authors
- Tara Kimura
is a multimedia producer for CBCNews.ca.
Categories
Recent Entries
- Seymour Custom Solvent recalled over labelling
- Health Canada has recalled 16,000 Seymour Custom Solvent Blend and Water Blend aerosol products because they do not meet mandatory warning labelling requirements.... Continue reading this post
- Kids eyeglass cases recalled because of lead levels
- About 1,500 childrens' eyeglass cases have been recalled because paint on the cases contains lead levels in excess of federal standards.... Continue reading this post
- GUND board books pose choking hazard
- GUND Inc. and Health Canada have recalled three baby books because they come with a plastic handle that can separate from the book bind and pose a choking hazard.... Continue reading this post